Thomas M. Kollmeyer

Mayo Clinic — United States

Medicine · Health Sciences

28h-index5.9kcitations135works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(101), Epigenetics and DNA Methylation(28), Radiomics and Machine Learning in Medical Imaging(22), MicroRNA in disease regulation(21), Cancer Genomics and Diagnostics(19)

Publications135 total

Clinical Implications of Aberrant Retinoblastoma Signaling in Patients With Grade 4 IDH-Mutant Astrocytoma
Neurology·2025
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i> -wildtype
Neuro-Oncology Advances·2025Open Access
PATH-82. Multivariate survival risk stratification in GBMs lacking necrosis and microvascular proliferation
Neuro-Oncology·2025Open Access
IMG-38. Differentiating adult diffuse IDH-mutant glioma from molecular glioblastoma IDH-wildtype using deep learning on MRI
Neuro-Oncology·2025Open Access
OS09.5.A RECURRENT COPY NUMBER ALTERATIONS DRIVE IDH-MUTANT ASTROCYTOMA DEVELOPMENT AND PROGRESSION
Neuro-Oncology·2025Open Access
Optimized Synthetic Flavonols Support Senescence Clearance and Lung Fibrosis Resolution
ACS Pharmacology & Translational Science·2025Open Access
<i>EGFR</i> transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype?
Journal of Neuropathology & Experimental Neurology·2025Open Access
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variants
Neuro-Oncology Advances·2025Open Access
EPCO-31. THE GERMLINE POLYMORPHISM RS55705857 IS ASSOCIATED WITH A POOR SURVIVAL IN ASTROCYTOMA, IDH-MUTANT, GRADE 2
Neuro-Oncology·2024Open Access
EPID-19. INTERACTION BETWEEN GERMLINE AND SOMATIC GENETICS TO ELUCIDATE RISK OF ADULT DIFFUSE GLIOMA
Neuro-Oncology·2024Open Access
TMOD-18. FUNCTIONAL DISSECTION OF RECURRENT COPY-NUMBER-ALTERATIONS INFORMS MECHANISMS OF LOW-GRADE-GLIOMA PROGRESSION
Neuro-Oncology·2024Open Access
Histopathologic and molecular profile of gliomas diagnosed in Lagos, Nigeria
Neuro-Oncology Practice·2024· 1 citedOpen Access
PATH-32. COMPARISON OF CLINICAL, RADIOGRAPHIC AND TUMOR GENOMIC ALTERATIONS BETWEEN CLASSIC AND MOLECULAR GLIOBLASTOMA (IDH WILDTYPE)
Neuro-Oncology·2023Open Access
NIMG-26. DIFFERENTIATION OF <i>IDH</i>-WILDTYPE GLIOBLASTOMA AND TUMEFACTIVE MULTIPLE SCLEROSIS USING PRE-OPERATIVE BRAIN MRI AND DEEP LEARNING: RIGOROUS AND UNBIASED EXPERIMENTAL DESIGN AND ANALYTICAL APPROACH
Neuro-Oncology·2023Open Access
PATH-31. RECURRENT COPY NUMBER CHANGES IN GLIOBLASTOMA, IDH-WILDTYPE: ARE OTHER +7/-10 PATTERNS CLINICALLY RELEVANT?
Neuro-Oncology·2023Open Access
DISP-09. HISTOPATHOLOGIC AND MOLECULAR PROFILE OF GLIOMAS: A 9-YEAR RETROSPECTIVE STUDY OF CASES DIAGNOSED IN LAGOS NIGERIA
Neuro-Oncology·2023Open Access
83. Cytogenetic and molecular characterization of IDH-mutant adult-type diffuse gliomas with near-total 1p/19q co-deletions
Cancer Genetics·2023
GLIOMA-02 HISTOPATHOLOGIC AND MOLECULAR PROFILE OF GLIOMAS: A 9-YEAR RETROSPECTIVE STUDY OF CASES DIAGNOSED IN LAGOS NIGERIA
Neuro-Oncology Advances·2023Open Access
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
Cell Reports Medicine·2023· 5 citedOpen Access
Clonally Selected Lines After CRISPR-Cas Editing Are Not Isogenic
The CRISPR Journal·2023· 14 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Robert B. Jenkins(44), Daniel H. Lachance(23), Paul A. Decker(19), Jeanette E. Eckel‐Passow(17), Caterina Giannini(16), Margaret Wrensch(16), John K. Wiencke(15), Terri Rice(13), Lucie McCoy(12), Matthew Kosel(12), Hugues Sicotte(11), Brian Patrick O’Neill(11), Karla V. Ballman(11), Alissa Caron(10), Helen M. Hansen(9), Paige M. Bracci(9), Tarık Tihan(9), Joseph L. Wiemels(9), Kristen Drucker(9), Kyle M. Walsh(8)